Akten Approval History
FDA Approved: Yes (First approved October 7, 2008)
Brand name: Akten
Generic name: lidocaine hydrochloride
Dosage form: Ophthalmic Gel
Company: Akorn, Inc.
Treatment for: Ocular Anesthesia
Akten (lidocaine hydrochloride) Ophthalmic Gel is a topical, ocular anesthetic formulation for use in ocular procedures that require a topical anesthetic agent.
Development History and FDA Approval Process for Akten
|Oct 8, 2008||Akorn, Inc. Announces the FDA Approval of Akten Ophthalmic Gel 3.5%|
|Jun 4, 2008||Akorn, Inc. Receives NDA Approvable Letter for Akten Ophthalmic Gel 3.5%|
|Jun 29, 2007||Akorn, Inc. Announces the New Drug Application Filing for Akten|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.